WHAT’S STOPPING DOCTORS REPURPOSING GENERIC MEDICINES? ANSWER—NOT A LOT!

If only they knew this during SARS-CoV-2

[Note: This article appeared in GMP Review AUG/SEPT 2021 when Hedley was helping Dr Tess Lawrie as Director, New Product Development & Supply, EbMCsquared CiC]

WHAT’S STOPPING DOCTORS REPURPOSING GENERIC MEDICINES?

For decades, it has been assumed only pharmaceutical companies have the wherewithal to develop or repurpose medicines.  This article challenge…